Ann Arbor, Mich.-based CytoPherx has secured $34 million in a financing round, which is said to be the biggest amount of venture capital funding for an in-state firm since April 2009. The company, which develops patent-protected and customized designs of existing hollow fiber dialysis filters for inflammation treatment, will use the money to advance clinical studies.

Related Summaries